Re-Essure study

• Conditions: Essure, sterilization, implants, nickel

• Registration Number: NL-OMON29147

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Other
• Sex: Not specified
• Target Recruitment: 3000

Inclusion Criteria

All women with Essure implants

Exclusion Criteria

Women who do not want to participate

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
symptom reduction at 12 months after removal.

Secondary Outcome Measures

Name	Time	Method
Quality of life (SF36) and satisfaction.